Ebit Alterar Data
AbbVie USD 4.73B 1.08B 2026-03
Abbott USD 1.85B 684M 2026-03
Bayer EUR 1.11B 1.51B 2025-12
Bristol-Myers Squibb USD 3.56B 90M 2026-03
Coherus Biosciences USD -39.08M 3.65M 2025-12
Corcept Therapeutics USD -49.6M 54.09M 2026-03
Dr.Reddys Laboratories INR 13.94B 1.79B 2025-12
Eli Lilly USD 9.78B 792M 2026-03
J&J USD 6.62B 1.51B 2026-03
Merck USD -1.88B 8.12B 2026-03
Nestle CHF 6.84B 293M 2025-12
Pacira USD 4.62M 1.43M 2026-03
Perrigo USD 33.6M 50.8M 2026-03
Pfizer USD 4.99B 340M 2026-03
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 82.49M 2.82M 2025-12
Reckitt Benckiser GBP 1.79B 109M 2024-12
Sanofi EUR 1.94B 239M 2026-03
Supernus Pharmaceuticals USD -35.25M 49.07M 2026-03
Teva Pharmaceutical Industries USD 758M 181M 2026-03
Xeris Pharmaceuticals USD 16.77M 8.88M 2025-12
Zoetis USD 835M 140M 2025-12